FRESENIUS MEDICAL CARE AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.51 USD | +0.62% |
|
+5.98% | -6.43% |
| 07:30am | FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan reiterates its Sell rating | ZD |
| Apr. 16 | STOXX 600 nears six-week low on geopolitical jitters; Ericsson shines | RE |
| Sales 2024 * | 19.68B 20.98B | Sales 2025 * | 20.39B 21.74B | Capitalization | 10.69B 11.4B |
|---|---|---|---|---|---|
| Net income 2024 * | 726M 774M | Net income 2025 * | 972M 1.04B | EV / Sales 2024 * | 1.05 x |
| Net Debt 2024 * | 10.07B 10.74B | Net Debt 2025 * | 9.47B 10.1B | EV / Sales 2025 * | 0.99 x |
| P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
11.1
x | Employees | 119,845 |
| Yield 2024 * |
2.98% | Yield 2025 * |
3.58% | Free-Float | 67.83% |
More Fundamentals
* Assessed data
More news
Latest transcript on Fresenius Medical Care AG
More recommendations
More press releases
| 1 day | +2.21% | ||
| 1 week | +2.43% | ||
| Current month | +0.57% | ||
| 1 month | +1.89% | ||
| 3 months | +0.05% | ||
| 6 months | +12.86% | ||
| Current year | -6.91% |
1 week
18.48
19.41
1 month
18.3219.71
Current year
18.3221.48
1 year
16.3727.72
3 years
12.7942.45
5 years
12.7946.55
10 years
12.7957.94
| Managers | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 56 | 19-10-31 |
Martin Fischer
DFI | Director of Finance/CFO | 47 | 23-09-30 |
Franklin Maddux
CTO | Chief Tech/Sci/R&D Officer | 65 | 08-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 16-05-11 |
Shervin Korangy
BRD | Director/Board Member | 50 | 23-07-13 |
Marcus Kuhnert
BRD | Director/Board Member | 56 | 23-07-13 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 19.49 | +0.52% | 181 370 |
| 24-04-18 | 19.39 | +2.21% | 625,142 |
| 24-04-17 | 18.97 | +1.99% | 278,277 |
| 24-04-16 | 18.6 | -0.91% | 347,436 |
| 24-04-15 | 18.77 | +2.07% | 516,069 |
Delayed Quote Nyse, April 18, 2024 at 04:00 pm EDT
More quotes
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
2024-05-06
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.43
EUR
Average target price
38.95
EUR
Spread / Average Target
+6.92%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.12% | 87.46B | |
| +9.72% | 78.56B | |
| +10.85% | 29.37B | |
| -12.25% | 16.78B | |
| -4.92% | 16.01B | |
| -8.68% | 13.98B | |
| +0.81% | 12.31B | |
| -30.53% | 12.07B | |
| +20.38% | 11.06B |
- Stock Market
- Equities
- FME Stock
- FMS Stock
